Taylor Is Sharfstein's Temporary Replacement As FDA's Second-In-Command
This article was originally published in The Rose Sheet
Executive Summary
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Joshua Sharfstein's departure.
You may also be interested in...
FDA's Dickinson Named Acting Chief Counsel Following Tyler’s Departure
FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler.
FDA's Dickinson Named Acting Chief Counsel Following Tyler’s Departure
FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler.
FDA Unveils Plan To Boost Transparency To Industry
FDA has identified 19 steps to improve its communications with drug and medical device manufacturers, promising quicker responses to industry questions.